Bluejay Diagnostics (BJDX) EBITDA (2020 - 2026)
Bluejay Diagnostics (BJDX) EBITDA from Mar 31, 2020 to Mar 31, 2026. The TTM Bluejay Diagnostics (BJDX) EBITDA is -$6.92M. You can adjust inflation or export chart.
All data is split-adjusted. You can find the most accurate data from the reports on the SEC official website. We recommend verify information using official company filings before making investment decisions.
Annual EBITDA
Quarterly EBITDA
Bluejay Diagnostics (BJDX) EBITDA CAGR table
| Period | CAGR |
|---|---|
| 1 Year TTM | +5.49% |
| 3 Years TTM | -10.65% |
| 5 Years TTM | +49.71% |
| All Time TTM | +49.72% |
Annual EBITDA change of Bluejay Diagnostics (BJDX)
| Year | EBITDA | Change |
|---|---|---|
| 2026 | -$1.91M | -72.24% |
| 2025 | -$6.88M | -2.96% |
| 2024 | -$7.09M | -26.60% |
| 2023 | -$9.66M | +5.46% |
| 2022 | -$9.16M | +197.40% |
| 2021 | -$3.08M | +196.15% |
| 2020 | -$1.04M | N/A |
Comparison Bluejay Diagnostics (BJDX) five years EBITDA CAGR with competitors
Bluejay Diagnostics (BJDX) five years EBITDA CAGR is 49.55%.